Jarislowsky, Fraser Ltd
- SEC CIK
- 0001123778
- Latest filing
- Oct 21, 2025
DGX holding history
Quest Diagnostics Inc in every 13F filed by Jarislowsky, Fraser Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DGX overviewAll 13F holders of DGXFull Q3 2025 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −1,735−100.0% | Sold out | Holders |
| Q3 2023 | 1,735 | $211.4K | <0.1% | −250−12.6% | Reduced | Holders |
| Q2 2023 | 1,985 | $279.0K | <0.1% | −115−5.5% | Reduced | Holders |
| Q1 2023 | 2,100 | $297.1K | <0.1% | −600−22.2% | Reduced | Holders |
| Q4 2022 | 2,700 | $422.4K | <0.1% | −200−6.9% | Reduced | Holders |
| Q3 2022 | 2,900 | $355.0K | <0.1% | −1,075−27.0% | Reduced | Holders |
| Q2 2022 | 3,975 | $528.0K | <0.1% | −175−4.2% | Reduced | Holders |
| Q1 2022 | 4,150 | $567.0K | <0.1% | −4,857−53.9% | Reduced | Holders |
| Q4 2021 | 9,007 | $1.56M | <0.1% | −2,825−23.9% | Reduced | Holders |
| Q3 2021 | 11,832 | $1.72M | <0.1% | −275−2.3% | Reduced | Holders |
| Q2 2021 | 12,107 | $1.60M | <0.1% | −725−5.6% | Reduced | Holders |
| Q1 2021 | 12,832 | $1.65M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.